This symptom is part of a syndrome called cachexia, which affects about 80% of late-stage cancer patients, leading to severe muscle wasting and weight loss that leave patients bone thin despite ...

New research published in Science suggests apathy and lack of motivation are symptoms of a condition called cancer cachexia.

OSU scientists created nanoparticles that deliver anti-inflammatory drugs across the blood-brain barrier, offering hope for ...

Cachexia not only contributes to reduced quality of life but also limits a patient’s ability to tolerate or benefit from ...

Researchers have discovered a way to get anti-inflammatory medicine across the blood-brain barrier, opening the door to potential new therapies for a range of conditions, including Alzheimer's disease ...

Janowitz is a co-team lead for CANCAN, tackling the cachexia challenge set in 2020 by Cancer Grand Challenges, a research initiative co-founded by Cancer Research UK and the National Cancer Institute.

Historically, cachexia has not been fully understood. Also known as wasting syndrome, cachexia is often incorrectly viewed as simply an inevitable side effect to cancer and other chronic conditions.

Advanced cancer often leads to cachexia, a syndrome causing profound apathy in patients. New research reveals that cancer hijacks brain circuits controlling motivation, suggesting potential treatments ...

Actimed Therapeutics Ltd (“Actimed”), a UK based clinical stage specialty pharmaceutical company focused on bringing innovation to the treatment of cancer cachexia and other muscle wasting disorders, ...

In this study, researchers specifically looked at the hypothalamus as it pertains to cachexia, a deadly weight-loss condition associated with cancers of the ovaries, stomach, lungs and pancreas ...

The first patient has received TCMCB07 in a phase 2 trial to prevent weight loss in patients with metastatic colorectal cancer undergoing chemotherapy.